IPHYF Message Board Post 10809096 | Innate Pharma
home / stock / iphyf / iphyf message board
gablock1
(investorshangout)
Posted on: Mar/10/2014 10:53:12
Source: investorshangout
https://investorshangout.com/post/view?id=1310611
Stock_Tracker: Latest Innate Pharma (IPHYF) Headlines INNATE PHARMA : raises 20.3 million in a
News, Short Squeeze, Breakout and More Instantly...
-
Regulatory News: Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities ( Autorité des Marchés Financiers , or “ AMF ”) General Regulation, Innate Pharma SA (Euronext Pari...
-
SAR443579/IPH6101, ANKET ® platform lead asset, is a first-in-class NKp46/CD16-based NK cell engager targeting CD123 from a joint research collaboration between Innate Pharma and Sanofi, under development by Sanofi in R/R AML, B-ALL and HR-MDS SAR443579/IPH6101 continues ...
-
In heavily pretreated patients with mycosis fungoides, treatment with lacutamab results in meaningful anti-tumor activity regardless of baseline KIR3DL2 expression level. Lacutamab was well-tolerated with a safety profile consistent with prior studies. Innate will host a virtual KOL...